Goldman Sachs Group Analysts Give Symrise (FRA:SY1) a €96.00 Price Target

Goldman Sachs Group set a €96.00 ($111.63) price target on Symrise (FRA:SY1) in a research report released on Wednesday, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

SY1 has been the subject of a number of other reports. Warburg Research set a €89.00 ($103.49) price target on shares of Symrise and gave the stock a neutral rating in a report on Wednesday. Kepler Capital Markets set a €78.50 ($91.28) price target on shares of Symrise and gave the stock a neutral rating in a report on Tuesday, April 30th. Barclays set a €79.00 ($91.86) price target on shares of Symrise and gave the stock a neutral rating in a report on Thursday, August 8th. Deutsche Bank set a €94.00 ($109.30) price target on shares of Symrise and gave the stock a buy rating in a report on Wednesday, July 3rd. Finally, Morgan Stanley set a €81.00 ($94.19) price target on shares of Symrise and gave the stock a neutral rating in a report on Monday, July 15th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and six have given a buy rating to the company. The stock presently has an average rating of Hold and a consensus price target of €81.78 ($95.09).

SY1 opened at €81.12 ($94.33) on Wednesday. Symrise has a twelve month low of €56.96 ($66.23) and a twelve month high of €73.48 ($85.44). The company has a fifty day moving average of €83.05 and a 200-day moving average of €82.30.

Symrise Company Profile

Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.

Further Reading: Technical Analysis of Stocks and What It Means

Analyst Recommendations for Symrise (FRA:SY1)

Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.